Amphastar P (AMPH) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $26.49
• Market Cap: $1.30B
• P/E Ratio: 12.38
• EPS: $2.26
• 52-Week High: $31.26
• 52-Week Low: $20.39

Market Sentiment

Amphastar P currently has a Neutral sentiment score of -0.05.

About Amphastar P

Amphastar Pharmaceuticals, Inc. is a prominent specialty pharmaceutical company dedicated to the development, manufacturing, and commercialization of both generic and proprietary injectable, inhalation, and intranasal products. Primarily serving the U.S. market while expanding internationally in regions such as China and France, Amphastar leverages its advanced research and development expertise alongside a comprehensive manufacturing infrastructure to target critical therapeutic areas. With ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Amphastar P and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does AMPH pay dividends?

Amphastar P (AMPH) does not currently pay a regular dividend.

What is AMPH's P/E ratio?

Amphastar P has a price-to-earnings (P/E) ratio of 12.38.

What is AMPH's market cap?

Amphastar P (AMPH) has a market capitalization of $1.30B with a current stock price of $26.49.